Cidara Therapeutics Inc logo

Cidara Therapeutics Inc Share Price CDTX

$221.38

▲

0.06

(0.03%)

Last updated on

Bell Icon

This instrument is not available for trading on the INDmoney app on 6 Jan 2026

Check the interactive Cidara Therapeutics Inc Stock chart to analyse performance

Cidara Therapeutics Inc Key Stats

Check Cidara Therapeutics Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$221.32
Open
$221.32
Market Capitalization
$7.0B
Today's Volume
$2.7M
Revenue TTM
$0.0
EBITDA
$-159.8M
Earnings Per Share (EPS)
$-11.2
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-68.7%

Global Institutional Holdings in Cidara Therapeutics Inc

  • Name

    Holdings %

  • RA Capital Management, LLC

    13.27%

  • Bain Capital Life Sciences Investors, LLC

    9.86%

  • Point72 Asset Management, L.P.

    6.03%

  • Vivo Capital, LLC

    5.17%

  • COMMODORE CAPITAL LP

    4.63%

  • BlackRock Inc

    4.37%

Analyst Recommendation on Cidara Therapeutics Inc Stock

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Cidara Therapeutics Inc(by analysts ranked 0 to 5 stars)

About Cidara Therapeutics Inc

Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.
Organization
Cidara Therapeutics Inc
Employees
38
CEO
Dr. Jeffrey L. Stein Ph.D.
Industry
Health Technology

Key Management of Cidara Therapeutics Inc

NameTitle
Dr. Jeffrey L. Stein Ph.D.
President, CEO & Executive Director
Dr. Leslie Tari Ph.D.
Chief Scientific Officer
Mr. Frank L. Karbe M.B.A.
Chief Financial Officer
Mr. Shane M. Ward J.D.
COO & Corporate Secretary
Ms. Allison Lewis CCP, SPHR
Senior Vice President of People & Culture
Dr. Nicole Davarpanah J.D., M.D.
Chief Medical Officer
Mr. Jim Beitel M.B.A.
Chief Business Officer
Ms. Corrina Pavetto
Senior Vice President of Clinical Development

Important FAQs about investing in CDTX Stock from India :

What is Cidara Therapeutics Inc share price today?

Cidara Therapeutics Inc share price today is $221.38 as on at the close of the market. Cidara Therapeutics Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Cidara Therapeutics Inc share?

Cidara Therapeutics Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Cidara Therapeutics Inc stock price today i.e. is closed at $221.38, lower by 0.02% versus the 52 week high.

How to invest in Cidara Therapeutics Inc Stock (CDTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cidara Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cidara Therapeutics Inc Shares that will get you 0.0068 shares as per Cidara Therapeutics Inc share price of $221.38 per share as on January 6, 2026 at 12:00 am IST.

What is the minimum amount required to buy Cidara Therapeutics Inc Stock (CDTX) from India?

Indian investors can start investing in Cidara Therapeutics Inc (CDTX) shares with as little as ₹94.77 or $1 (as of June 24, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹947.70 in Cidara Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on June 24, 2026). Based on Cidara Therapeutics Inc share’s latest price of $221.38 as on January 6, 2026 at 12:00 am IST, you will get 0.0452 shares of Cidara Therapeutics Inc. Learn more about fractional shares .

What are the returns that Cidara Therapeutics Inc has given to Indian investors in the last 5 years?

Cidara Therapeutics Inc stock has given 0.0% share price returns and 27.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?